Glenmark Pharma’s Q3 consolidated net profit declines 47%

13 Feb 2015 Evaluate

Glenmark Pharmaceuticals has reported results for third quarter ended December 31, 2014.

The company has registered a rise of 99.85% in its net profit at Rs 116.73 crore for the quarter under review as compared to Rs 58.41 crore for the same quarter in the previous year. Total income of the company increased by 23.23% at Rs 669.30 crore for Q3FY15 as compared Rs 543.12 crore for the corresponding quarter previous year.

On the consolidated basis the company’s net profit after tax and minority interest declined 46.92% to Rs 114.77 crore for the Q3 FY15, as compared to Rs 216.24 crore in Q3 FY14. However, the total income increased 6.01% to Rs 1703.43 crore in the quarter under review as compared to Rs 1606.83 crore in the corresponding quarter previous year.

Glenmark Pharma Share Price

1540.70 -52.20 (-3.28%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.